Trump administration sees FDA enforcement actions decline
A study has shown the warning letters the FDA distributes have decreased by a third since Trump came to office.
List view / Grid view
A study has shown the warning letters the FDA distributes have decreased by a third since Trump came to office.
Macleods has issued a recall of 32 lots of drug products that contained trace amounts of NMBA impurities.
AstraZeneca today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to add a self-administration option for Fasenra (benralizumab) and a new delivery method as a pre-filled, single-use auto-injector (the Fasenra pen) to the medicine’s product information in the European…
An injection to treat NMOSD has been given approval by the FDA and has received orphan drug designation.
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
The MHRA has given marketing authorisation for short-term jet-lag therapy in adults.
The ABPI has reported findings from its transparency initiative, Disclosure UK, stating that R&D investment grew significantly from 2017 to 2018.
Former FDA Commissioner, Scott Gottlieb, who stepped down from the administration in April, has joined Pfizer’s board of directors.
A team at the Technical University of Munich have made it possible for nano particles to be released in sequence with the use of artificial DNA.
The EMA has given its approval recommendation to three drugs and announced negative opinions for approval on others.
A report has projected that by 2025, the global cryo-electron microscope market will be worth US$632.3 million.
Pharmaceutical company Pfizer was able to target the distribution of counterfeit Viagra in Hong Kong through serialisation technology.
Researchers have developed a new drug delivery system that can be remotely controlled to administer patients with medication.
A new report has stated that the majority of medical journals restrict their content for pharmaceutical industry professionals.
Researchers have discovered the formulation of glucagon fibrils, which could inform drug formulation for diabetic patients.